^
No biomarker
Germ Cell Tumors
dactinomycin
Sensitive
:
A1
No biomarker
Germ Cell Tumors
ifosfamide
Sensitive
:
A1
No biomarker
Germ Cell Tumors
TI-CE
Sensitive
:
A2
No biomarker
Germ Cell Tumors
CaT
Sensitive
:
A2
No biomarker
Germ Cell Tumors
EC
Sensitive
:
A2
No biomarker
Germ Cell Tumors
GemOx
Sensitive
:
A2
No biomarker
Germ Cell Tumors
BEP
Sensitive
:
A2
No biomarker
Germ Cell Tumors
EP
Sensitive
:
A2
No biomarker
Germ Cell Tumors
VIP
Sensitive
:
A2
No biomarker
Germ Cell Tumors
VAC
Sensitive
:
A2
No biomarker
Germ Cell Tumors
VeIP
Sensitive
:
A2
No biomarker
Germ Cell Tumors
TIP
Sensitive
:
A2
TMB-H
Germ Cell Tumors
pembrolizumab
Sensitive
:
A2
No biomarker
Germ Cell Tumors
paclitaxel + ifosfamide
Sensitive
:
A2
No biomarker
Germ Cell Tumors
gemcitabine + paclitaxel
Sensitive
:
A2
No biomarker
Germ Cell Tumors
paclitaxel
Sensitive
:
A2
No biomarker
Germ Cell Tumors
carboplatin + docetaxel
Sensitive
:
A2
No biomarker
Germ Cell Tumors
docetaxel
Sensitive
:
A2
No biomarker
Germ Cell Tumors
etoposide IV
Sensitive
:
A2
No biomarker
Germ Cell Tumors
gemcitabine + paclitaxel + oxaliplatin
Sensitive
:
A2
MSI-H/dMMR
Germ Cell Tumors
pembrolizumab
Sensitive
:
A2
BRCA1 mutation
Germ Cell Tumors
olaparib
Sensitive
:
C1
XPA expression
Germ Cell Tumors
cisplatin
Resistant
:
C3
MTOR mutation
Germ Cell Tumors
everolimus
Sensitive
:
C3
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our